Germline BRCA1 and BRCA2 mutations in patients with HER2-negative metastatic breast cancer (mBC) treated with first-line chemotherapy: Data from the German PRAEGNANT registry.

被引：4
|
作者：
Fasching, Peter A.
Hu, Chunling
Hart, Steven
Hartkopf, Andreas D.
Taran, Florin A.
Janni, Wolfgang
Tesch, Hans
Haeberle, Lothar
Ettl, Johannes
Overkamp, Friedrich
Lux, Michael P.
Luftner, Diana
Wallwiener, Markus
Mueller, Volkmar
Kolberg, Hans-Christian
Fehm, Tanja N.
Wallwiener, Diethelm
Brucker, Sara
Schneeweiss, Andreas
Couch, Fergus
机构：
[1] Univ Hosp Erlangen, Erlangen, Germany
[2] Mayo Clin, Rochester, MN USA
[3] Univ Tubingen, Dept Gynecol & Obstet, Tubingen, Germany
[4] Dept Obstet & Gynecol, Tubingen, Germany
[5] Univ Ulm, Ulm, Germany
[6] Hamatol Onkol Gemeinschaftspraxis Bethanien, Frankfurt, Germany
[7] Dept Biometry Epidemiol, Erlangen, Germany
[8] Oberarzt Frauenk, Munich, Germany
[9] Oncologianova GmbH, Recklinghausen, Germany
[10] Univ Breast Ctr Franconia, Dept Obstet & Gynaecol, Erlangen, Germany
[11] Univ Hosp Berlin, Charite Campus Benjamin Franklin, Berlin, Germany
[12] Heidelberg Univ, Dept Obstet & Gynaecol, Heidelberg, Germany
[13] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[14] Marienhosp Bottrop, Klin Gynakol & Geburtshilfe, Bottrop, Germany
[15] Univ Duesseldorf, Dusseldorf, Germany
[16] Tuebingen Univ Hosp, Dept Womens Hlth, Tubingen, Germany
[17] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany
[18] German Canc Res Ctr, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.1048
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1048
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Response to first line chemotherapy in BRCA1 and BRCA2 mutation carriers with metastatic breast cancer (MBC)
    Kriege, M.
    Seynaeve, C.
    Meijers-Heijboer, H.
    Collee, J. M.
    Menke-Pluijmers, M. B. E.
    Bartels, C. C. M.
    van den Ouweland, A.
    Hooning, M. J.
    Brekelmans, C. T. M.
    Klijn, J. G. M.
    EJC SUPPLEMENTS, 2008, 6 (07): : 109 - 109
  • [2] Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
    Kriege, Mieke
    Seynaeve, Caroline
    Meijers-Heijboer, Hanne
    Collee, J. Margriet
    Menke-Pluymers, Marian B. E.
    Bartels, Carina C. M.
    Tilanus-Linthorst, Madeleine M. A.
    Blom, Jannet
    Huijskens, Elisabeth
    Jager, Agnes
    van den Ouweland, Ans
    van Geel, Bert
    Hooning, Maartje J.
    Brekelmans, Cecile T. M.
    Klijn, Jan G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : 3764 - 3771
  • [3] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Wong-Brown, Michelle W.
    Meldrum, Cliff J.
    Carpenter, Jane E.
    Clarke, Christine L.
    Narod, Steven A.
    Jakubowska, Anna
    Rudnicka, Helena
    Lubinski, Jan
    Scott, Rodney J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
  • [4] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Michelle W. Wong-Brown
    Cliff J. Meldrum
    Jane E. Carpenter
    Christine L. Clarke
    Steven A. Narod
    Anna Jakubowska
    Helena Rudnicka
    Jan Lubinski
    Rodney J. Scott
    Breast Cancer Research and Treatment, 2015, 150 : 71 - 80
  • [5] BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
    Keshavarzi, Fatemeh
    Javadi, Gholam Reza
    Zeinali, Sirous
    FAMILIAL CANCER, 2012, 11 (01) : 57 - 67
  • [6] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
    Zhang, Yinmei
    Wu, Heming
    Gan, Caiyan
    Rao, Hui
    Wang, Qiuming
    Guo, Xueming
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [7] BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
    Fatemeh Keshavarzi
    Gholam Reza Javadi
    Sirous Zeinali
    Familial Cancer, 2012, 11 : 57 - 67
  • [8] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
    Yinmei Zhang
    Heming Wu
    Caiyan Gan
    Hui Rao
    Qiuming Wang
    Xueming Guo
    BMC Medical Genomics, 17
  • [9] Mutations of the BRCA1 and BRCA2 genes in German breast cancer patients
    Skawran, B
    Bremer, M
    Stuhrmann, M
    Volkmann, C
    Schmidtke, J
    Karstens, JH
    Dörk, T
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 120 - 120
  • [10] BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients
    Alex Friedlaender
    Aurélie Vuilleumier
    Valeria Viassolo
    Aurélie Ayme
    Solène De Talhouet
    Jean-Damien Combes
    Julien Peron
    Alexandre Bodmer
    Sophie Giraud
    Adrien Buisson
    Valerie Bonadona
    Isabelle Gauchat-Bouchardy
    Olivier Tredan
    Pierre O. Chappuis
    S. Intidhar Labidi-Galy
    Breast Cancer Research and Treatment, 2019, 174 : 775 - 783
12345